<< back

Vanaheim Group Pty Ltd, ACN 111 717 429

JIM GOTTSTEIN, ZYPREXA AND ELI LILLY

Jim Gottstein is the founder and CEO of the Law Project for Psychiatric Rights' (PsychRights), and a friend of Vanaheim Group.

He is the subject of legal proceedings issued by US pharmaceutical company Eli Lilly. These proceedings relate to Jim's assistance in releasing documents in respect of the anti-psychotic drug Zyprexa.

Vanaheim Group supports Jim Gottstein and his efforts to promote informed choice in respect of psychiatric drugs.

Jim Gottstein is experiencing financial hardship as a result of his efforts.

If you feel that Jim Gottstein’s efforts to promote informed choice in psychiatry should continue, please donate funds to allow him to continue.

Click here to dowload the latest press release from PsychRights (24kB).

Click here to DONATE to PsychRights

(via PsychRights web page)

If you wish to pay by cheque (in US dollars), the ICSPP has set up a legal defence fund here.